COMPOSITIONS FOR TREATMENT OF WET AGE-REALTED MACULAR DEGENERATION
Last updated:
Abstract:
A liquid suspension product comprising a recombinant adeno-associated virus (rAAV) having an AAV8 capsid which is suitable for intra-retinal injection is provided herein. Also provided herein are liquid suspensions containing these rAAV8.aVEGF and methods of using same for treatment of wet AMD and other ocular conditions.
Status:
Application
Type:
Utility
Filling date:
18 Feb 2019
Issue date:
1 Apr 2021